CD22 and systemic lupus erythematosus: In this study, we found that the slower‐internalizing type II anti‐CD20 mAb depleted B cells from patients with RA and SLE more efficiently than either type I anti‐CD20 or anti‐CD22 mAb and that internalization influenced the efficiency of depletion.